RCEL
Avita Medical, Inc. Common StockstockNASDAQ
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company's lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 17.30 | 2026-11-11 | -2.89% | -1.985 |
| 1M | 13.14 | 2026-10-19 | +27.85% | 1.553 |
| 3M | 9.85 | 2026-08-18 | +70.56% | 1.716 |
| 6M | 4.19 | 2026-05-18 | +300.95% | 1.494 |
| 1Y | 3.95 | 2025-11-18 | +325.32% | 1.613 |
| 2Y | 12.43 | 2024-11-18 | +35.16% | — |
| 5Y | 15.40 | 2021-11-18 | +9.09% | 1.427 |
Avita Medical, Inc. Common Stock (NASDAQ:RCEL) stock price today is $16.80, and today's volume is 716,045. RCEL is up 6.531% today. The 30 day average volume is 522,990. RCEL market cap is $532.35M with 31.69M shares outstanding.